MindBio Therapeutics Corp (MBIO)
NEO
0.2400
+0.0050 (+2.13%)
Real-time Data
01:30 PM
Day's Range
0.24000.2400
52 wk Range
0.005001.49
Overview - MBIO - MindBio Therapeutics Corp
Key Statistics
Trading
Volume
75
Average Volume
1.07K
Peers - MBIO - MindBio Therapeutics Corp
Peer Comparison
Compared with companies in Biotechnology listed on NEO.
- MBIONEOMindBio Therapeutics Corp+97.92%52-week change—P/E (Trailing)—Profit Margin
- BMNDNEOBiomind Labs Inc.+49.27%52-week change-69.00P/E (Trailing)‪0.00%‬Profit Margin
- BOLTNEO26 Metals Inc.+97.50%52-week change—P/E (Trailing)—Profit Margin
- BETRNEOBetterLife Pharma Inc.+73.33%52-week change—P/E (Trailing)—Profit Margin
- APMNEOAndean Precious Metals Corp.+33.77%52-week change—P/E (Trailing)—Profit Margin
- BLABNEOBritannia Life Sciences Inc.-26.67%52-week change—P/E (Trailing)—Profit Margin
- ARCHNEOArch Biopartners Inc.-66.67%52-week change—P/E (Trailing)—Profit Margin
Profile Summary - MBIO - MindBio Therapeutics Corp
About
MindBio Therapeutics Corp is a publicly traded innovation company focused on developing and commercializing AI-powered health prediction technologies using human voice biomarkers. The company pioneers acoustic biomarker technology that transforms human voice into actionable health intelligence, enabling real-time…
SectorHealthcare
IndustryBiotechnology
Employees0
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
